Our data presented here are consistent with previous findings and further experimentally confirmed that PTC-209 is a potent inhibitor of Bmi1 in HNSCC as evidenced by remarkable downregulation of Bmi1 in vitro and in vivo. Here, BMI1 is linked to head and neck squamous cell carcinoma.